Association between arthritis and cardiovascular risk factors in community-based adults: an opportunity to target

Julia Sewell1, Sultana Monira Hussain1, Yuanyuan Wang1

  • 1Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC, 3004, Australia.

Insights

Adults with arthritis have higher odds of cardiovascular disease risk factors like obesity and hypertension. Targeting arthritis could reduce these risks by 20-30%.

Area of Science:

  • Public Health
  • Epidemiology
  • Cardiovascular Health

Background:

  • Cardiovascular disease (CVD) burden is high, exacerbated by undertreated risk factors.
  • Arthritis is linked to increased prevalence of CVD risk factors, often asymptomatic.
  • Arthritis-related pain and immobility drive healthcare visits, presenting screening opportunities.

Purpose of the Study:

  • Examine the association between arthritis and CVD risk factors in Australian adults.
  • Quantify the potential reduction in CVD risk factors by targeting individuals with arthritis.

Main Methods:

  • Cross-sectional study using 2017-18 Australian National Health Survey data (n=13,776).
  • Categorized participants into young (18-39), middle-aged (40-64), and older (≥65) adults.
  • Used logistic regression to analyze associations and calculated population attributable fraction (PAF).

Main Results:

  • Arthritis prevalence: 4.0% (young), 28.8% (middle-aged), 54.5% (older adults).
  • Increased odds of obesity, diabetes, hypertension, and dyslipidemia in adults with arthritis across age groups.
  • PAF for at least one CVD risk factor due to arthritis: 30.7% (middle-aged) and 70.4% (older adults).

Conclusions:

  • Adults with arthritis have significantly higher odds of CVD risk factors, even after adjusting for obesity.
  • Healthcare encounters for arthritis offer a crucial opportunity for CVD risk factor screening.
  • Parallel management of arthritis and CVD risk factors could reduce CVD risk factor burden by 20-30%.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
48
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
74
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
44
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
57
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
39
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
81